Intercept Pharmaceuticals Inc (ICPT) Price Targets From Analysts
Use the tables below to see what analysts covering Intercept Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ICPT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ICPT as an investment opportunity.
- ICPT has a lower percent of analysts bearish on the stock than nearly 100% of all US stocks.
- ICPT has a greater number of analysts covering the stock than 99.6% of stocks in the mid market cap category.
- The variance in analysts' estimates of ICPT is less than 1.2% of stocks in the mid market cap category.
- Intercept Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 92.15% of stocks in the mid market cap category.
- ICPT has a higher percentage of analysts bullish on the stock than 11% of Healthcare stocks.
- The average analyst price target of ICPT is greater than 82.04% of Pharmaceutical Products stocks.
- ICPT has a less change in bullishness amongst analysts than nearly 100% of all US stocks.
Is ICPT a Buy, Hold or Sell? See the POWR Ratings now!